Defining and Demonstrating Value in Rare Disease
Day 2 • Tuesday, December 8th | 3:00pm - 3:45pm
Michelle Leeds, Vice President, Reputation & Risk Management
The Path from Clinical to Commercialization
On Demand Session
David Thompson, SVP, Real World and Late Phase
